mRNA vaccine-a desirable therapeutic strategy for surmounting COVID-19 pandemic

被引：7
作者：
Chen, Peixian [1 ]
Shi, Xiaoye [1 ]
He, Weixin [2 ]
Zhong, Guowei [3 ]
Tang, Yan [1 ]
Wang, Hailin [4 ]
Zhang, Peidong [5 ]
机构：
[1] Southern Med Univ, Sch Clin Med 2, Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Sch Clin Med 1, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
[3] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China
[4] Peoples Hosp Guangning Cty, Heart Ctr, Dept Cardiol, 18 Renmin Rd, Zhaoqing City 526300, Guangdong, Peoples R China
[5] Southern Med Univ, Zhujiang Hosp, Heart Ctr, Dept Cardiol, Guangzhou, Guangdong, Peoples R China
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2022年 / 18卷 / 01期
关键词：
COVID-19; mRNA vaccines; infectious diseases; immune responses; clinical trial; SARS-CoV-2; UNITED-STATES; BNT162B2; IMMUNOGENICITY; MYOCARDITIS; VECTOR; SAFETY; 1ST;
D O I：
10.1080/21645515.2022.2040330
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
As an acute respiratory infectious disease, COVID-19 threatens the safety of global public health. Given the current lack of specific treatment against this disease, research and development of vaccines have become sharp weapons for overcoming the pandemic. mRNA vaccines have become the lead in COVID-19 vaccination strategies due to their advantages, such as rapid industrial production and efficacy. A total of 137 COVID-19 vaccines have entered the clinical trial stage, among which 23 are mRNA vaccines, accounting for 17% of the total vaccines. Herein, we summarize the research and developmental processes of mRNA vaccines as well as the approach for protecting the human body against infection. Focusing on the latest clinical trial data of two COVID-19 mRNA vaccines from Pfizer and Modena, we discuss their effectiveness and safety. Finally, we analyze the challenges and problems that mRNA vaccines face in controlling the COVID-19 pandemic.
引用
收藏
页数：13
相关论文
共 110 条
  • [11] Bajema KL, 2021, MMWR-MORBID MORTAL W, V70, P1700, DOI 10.15585/mmwr.mm7049a2
  • [12] mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach
    Banerji, Aleena
    Wickner, Paige G.
    Saff, Rebecca
    Stone, Cosby A.
    Robinson, Lacey B.
    Long, Aidan A.
    Wolfson, Anna R.
    Williams, Paul
    Khan, David A.
    Phillips, Elizabeth
    Blumenthal, Kimberly G.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (04) : 1423 - 1437
  • [13] Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study
    Barda, Noam
    Dagan, Noa
    Cohen, Cyrille
    Hernan, Miguel A.
    Lipsitch, Marc
    Kohane, Isaac S.
    Reis, Ben Y.
    Balicer, Ran D.
    [J]. LANCET, 2021, 398 (10316) : 2093 - 2100
  • [14] BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers
    Benenson, Shmuel
    Oster, Yonatan
    Cohen, Matan J.
    Nir-Paz, Ran
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (18) : 1775 - 1777
  • [15] Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
    Bergwerk, Moriah
    Gonen, Tal
    Lustig, Yaniv
    Amit, Sharon
    Lipsitch, Marc
    Cohen, Carmit
    Mandelboim, Michal
    Gal Levin, Einav
    Rubin, Carmit
    Indenbaum, Victoria
    Tal, Ilana
    Zavitan, Malka
    Zuckerman, Neta
    Bar-Chaim, Adina
    Kreiss, Yitshak
    Regev-Yochay, Gili
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) : 1474 - 1484
  • [16] Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
    Bernal, Jamie Lopez
    Andrews, Nick
    Gower, Charlotte
    Gallagher, Eileen
    Simmons, Ruth
    Thelwall, Simon
    Stowe, Julia
    Tessier, Elise
    Groves, Natalie
    Dabrera, Gavin
    Myers, Richard
    Campbell, Colin N. J.
    Amirthalingam, Gayatri
    Edmunds, Matt
    Zambon, Maria
    Brown, Kevin E.
    Hopkins, Susan
    Chand, Meera
    Ramsay, Mary
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07) : 585 - 594
  • [17] Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine
    Bowman, Christopher J.
    Bouressam, Marie
    Campion, Sarah N.
    Cappon, Gregg D.
    Catlin, Natasha R.
    Cutler, Mark W.
    Diekmann, Jan
    Rohde, Cynthia M.
    Sellers, Rani S.
    Lindemann, Claudia
    [J]. REPRODUCTIVE TOXICOLOGY, 2021, 103 : 28 - 35
  • [18] Myocarditis With COVID-19 mRNA Vaccines
    Bozkurt, Biykem
    Kamat, Ishan
    Hotez, Peter J.
    [J]. CIRCULATION, 2021, 144 (06) : 471 - 484
  • [19] Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks - Connecticut, December 2020-February 2021
    Britton, Amadea
    Slifka, Kara M. Jacobs
    Edens, Chris
    Nanduri, Srinivas Acharya
    Bart, Stephen M.
    Shang, Nong
    Harizaj, Adora
    Armstrong, Jillian
    Xu, Kerui
    Ehrlich, Hanna Y.
    Soda, Elizabeth
    Derado, Gordana
    Verani, Jennifer R.
    Schrag, Stephanie J.
    Jernigan, John A.
    Leung, Vivian H.
    Parikh, Sunil
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2021, 70 (11): : 396 - 401
  • [20] Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study
    Bruxvoort, Katia J.
    Sy, Lina S.
    Qian, Lei
    Ackerson, Bradley K.
    Luo, Yi
    Lee, Gina S.
    Tian, Yun
    Florea, Ana
    Takhar, Harpreet S.
    Tubert, Julia E.
    Talarico, Carla A.
    Tseng, Hung Fu
    [J]. LANCET REGIONAL HEALTH-AMERICAS, 2022, 6
12345678910